Farmington healthcare software provider Evariant announced today it has raised $42.3 million in Series C financing.
The funding will allow the company to grow its engineering, services, and customer-success teams to expand its healthcare provider footprint.
Evariant recently opened its fourth office in Austin, Texas, that functions as the company’s technology hub.
Goldman Sachs led the funding round – with participation from Health Enterprise Partners and Lightspeed Venture Partners – and Jason Kreuziger of Goldman Sachs has joined the Evariant board of directors.
Evariant offers a healthcare customer relationship management (CRM) system that helps health systems attract profitable patient volume and connect patients with providers around their care in new value-based healthcare delivery models, according to Evariant’s news release. The technology aims to reduce the overall cost of care and improve the patient experience, it said.
“It is no secret that healthcare systems are facing a variety of complex market challenges,” Evariant CEO William Moschella said in the release. “These issues are not going to be solved by a collection of point solutions, but rather by an integrated platform that can scale and address the healthcare markets’ analytics and CRM needs of today and tomorrow. Our advances with big data and streaming analytics will yield significant market advantages to our customers. We are excited to leverage this additional investment to address core and new healthcare system requirements.”
